Aldeyra has outlined a fast path back to the FDA’s door. The biotech expects to meet with the agency within 30 days to discuss the CRL and to share top-line results from the ongoing dry eye ...

Miebo produced substantial symptom relief in patients with dry eye disease during the first ... researchers were surprised at “exactly how quick” Miebo worked. “When we combine it with ...